Molekule Group Stock Operating Margin
Molekule Group fundamentals help investors to digest information that contributes to Molekule's financial success or failures. It also enables traders to predict the movement of Molekule Stock. The fundamental analysis module provides a way to measure Molekule's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Molekule stock.
Molekule |
Molekule Group Company Operating Margin Analysis
Molekule's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Molekule Operating Margin | (1.47) % |
Most of Molekule's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Molekule Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
CompetitionBased on the recorded statements, Molekule Group has an Operating Margin of -1.4676%. This is 127.23% lower than that of the Machinery sector and 92.84% lower than that of the Industrials industry. The operating margin for all United States stocks is 73.36% lower than that of the firm.
Molekule Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Molekule's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Molekule could also be used in its relative valuation, which is a method of valuing Molekule by comparing valuation metrics of similar companies.Molekule is currently under evaluation in operating margin category among its peers.
Molekule Fundamentals
Return On Equity | -1.17 | |||
Return On Asset | -0.25 | |||
Profit Margin | (1.53) % | |||
Operating Margin | (1.47) % | |||
Current Valuation | 45.01 M | |||
Shares Outstanding | 34.65 M | |||
Shares Owned By Insiders | 33.02 % | |||
Shares Owned By Institutions | 30.70 % | |||
Number Of Shares Shorted | 775.6 K | |||
Revenue | 48.03 M | |||
Gross Profit | 277.62 K | |||
EBITDA | 8.34 M | |||
Net Income | (1.55 M) | |||
Total Debt | 46.72 M | |||
Book Value Per Share | 1.20 X | |||
Cash Flow From Operations | (41.28 M) | |||
Short Ratio | 0.78 X | |||
Earnings Per Share | (0.68) X | |||
Target Price | 7.0 | |||
Number Of Employees | 91 | |||
Market Capitalization | 1.87 M | |||
Total Asset | 52.32 M | |||
Retained Earnings | (7.92 M) | |||
Working Capital | 20.22 M | |||
Z Score | 1.72 | |||
Net Asset | 52.32 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Consideration for investing in Molekule Stock
If you are still planning to invest in Molekule Group check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Molekule's history and understand the potential risks before investing.
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Transaction History View history of all your transactions and understand their impact on performance | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |